HealthUpdatedJuly 15, 2026

Closing CORE USP 797 compliance gaps: Risk reduction strategies

Key Takeaways

  • Sterile compounding compliance gaps in competency, operations, recordkeeping, and environment pose serious patient safety and legal risks for pharmacies.
  • The CORE framework helps pharmacy leaders identify, document, and correct recurring USP 797 vulnerabilities before they become costly compliance failures.
  • Centralizing training, automating documentation, and standardizing SOPs with platforms like Simplifi 797 significantly reduces compliance gaps across all four CORE domains.
Sterile compounding compliance gaps emerge during growth, staffing changes, or outdated routines, and each one carries patient safety and legal risk. This article introduces the CORE framework, Competency, Operations, Records, and Environment, to help pharmacy leaders detect and correct recurring vulnerabilities to strengthen USP 797 compliance and reduce risk.

As sterile compounding continues to evolve, driven by both expanding demand and evolving technology, compliance gaps remain a challenge. For some pharmacies, those gaps emerge during periods of growth, such as increased GLP-1 demand, staffing expansion, or facility renovation. For others, they stem from legacy workflows, outdated documentation, or processes that have not been fully aligned with current USP <797> standards.

According to APC’s 2025-2026 annual compounding snapshot, 51% of pharmacies reported increasing staffing or personnel hours to meet GLP-1 demand, while 81% reported investing in facility updates to support USP 797 compliance. But even in pharmacies with stable operations, gaps often persist in training, environmental monitoring, cleaning, and documentation, particularly where longstanding practices have not kept pace with revised standards.

These gaps in 797 compliance not only pose a risk to patient safety but also carry legal risk. In sterile compounding litigation, USP 797 is often treated as the de facto standard of care, even in states where it has not been formally adopted into law. Whether the source is rapid operational change or outdated routine practice, compliance gaps represent not only patient safety risk, but also legal and business exposure.

For that reason, identifying where gaps emerge—and implementing systems to detect, document, and correct them—is essential to maintaining compliance, protecting patients, and reducing risk.

The CORE Framework for USP 797 Compliance

Across FDA Form 483 observations, industry data, and inspector findings, sterile compounding compliance vulnerabilities consistently emerge across four operational domains: Competency, Operations, Records, and Environment (CORE). Identifying these recurring failure points is essential to strengthening compliance, improving process control, and reducing risk.

Competency

Most compounding personnel are familiar with the baseline training expectations under USP 797, but competency-related deficiencies remain common, particularly as operational demands increase. As staffing expands, workflows accelerate, and new processes are introduced, training is often one of the first controls to drift. Particular attention should be paid to three recurring vulnerabilities:

  • Ongoing competency and retraining: NABP continues to identify deficiencies in ongoing training across both sterile and nonsterile compounding, particularly where retraining is either not documented or not performed at the required frequency. As workflow demands increase, maintaining training cadence and ensuring operational coverage during training becomes more difficult.
  • Media-fill design: Media-fill evaluations should reflect the most challenging manipulations performed in practice. This remains a common and readily correctable deficiency. Competency assessments should account for the most complex workflow conditions, including manipulation volume, batch size, and dynamic operating conditions. If using a commercial testing kit, it may need to be adapted to mimic the most complex conditions at your particular facility.
  • New equipment and process adoption: Whether implementing Category 3 compounding, introducing new compounding technologies, or transitioning to in-house testing, personnel conducting the testing must be trained and competency-assessed before use. Training for new technology should extend beyond basic operation to include routine maintenance, process verification, and interpretation of resulting data, with documentation maintained throughout.

Closing competency gaps: Standardize training

Standardize your training and automate the training schedule as much as possible. Ensure documents are readily retrievable for inspectors. NABP reports that many times, records were locked and not available during the inspection. Simplifi 797 centralizes education tools and competency tracking. The system tracks completions and flags overdue assessments, giving pharmacy leaders complete visibility into staff readiness and makes records quickly available. This reduces the burden of managing training programs while ensuring that only qualified personnel handle critical compounding tasks.

Operations

Breakdowns in routine process execution remain a common gap, particularly in workflow consistency, environmental monitoring, and cleaning and disinfection practices. SOPs should reflect actual practice: if there is a discrepancy between the SOP and routine practice, either staff need to be retrained, or SOPs need to be updated.

Common operational USP 797 compliance gaps

NABP continues to cite basic but critical lapses, such as failing to disinfect materials with sterile isopropyl alcohol (sIPA) and allow them to dry before transfer into the PEC, using incorrect agents (cleaning, sporicidal, sIPA), missing required USP <797> cleaning frequencies, or failing to follow proper technique. Cleaning and sporicidal agents should also be routinely checked for expiration, with required dwell times consistently observed. While some of these issues may require retraining, more often the problem is not knowledge—it is consistency, oversight, and documentation.

Environmental monitoring presents similar gaps. Common deficiencies include poorly documented sampling locations, missed sampling frequencies based on compounding activity, inadequate follow-up of out-of-specification results, and failure to investigate adverse trends before contamination occurs.

Closing operations gaps: monitor and follow-up

Inspection should not be the first time staff practices are evaluated. Routine observation and workflow audits are essential to identifying and correcting issues early. Beyond these recommendations, consider leveraging established tools rather than relying solely on manual processes. As compounding becomes more complex, manual checks and documentation alone are increasingly difficult to sustain and can create avoidable compliance vulnerabilities.

Simplifi 797 provides immediate access to a peer-reviewed content library of expert-vetted standard operating procedures for USP 797 compliance. You can deploy these ready-to-use templates across your enterprise to save hundreds of hours of development time. The platform also automates task management, prompting staff to complete daily tasks. Managers can view real-time compliance dashboards to ensure no tasks slip through the cracks during busy shifts.

Recordkeeping

Recordkeeping deficiencies are one of the most avoidable findings in compounding facilities. As long as documentation relies heavily on manual processes, missing, incomplete, or inaccessible records will remain a persistent risk. In sterile compounding, documentation is not just administrative—if it is not documented, it cannot be verified.

These deficiencies commonly appear across multiple areas of practice:

  • Temperature logs where excursions are not identified in real time due to manual recording; temperature not monitored in all storage areas.
  • Certifier reports that are accepted without review of underlying findings or trends; staff neglecting to verify that certifiers documented all necessary information, such as dynamic conditions or number of personnel.
  • Outdated master formulation and compounding records
  • Undocumented training
  • Undocumented accommodations made by the designated person without supporting evidence that the compounding environment was not impacted
  • Records exist but are not retrievable when needed

Closing recordkeeping gaps: digitize and centralize

A platform such as Simplifi 797 can reduce many common recordkeeping deficiencies by replacing manual documentation with centralized, readily retrievable records. Automated monitoring can identify excursions in real time, while digitized logs improve control over training, environmental monitoring, record versioning, and designated person documentation. It can centralize MFRs and CRs, and standardize required fields. In practice, tools like this help ensure critical records are not only completed, but accessible when needed.

Environment

Lastly, the environment of the facility itself can be a source of compliance gaps, such as deficiencies in cleanroom design, airflow, pressure differentials, layout, and engineering controls. Common findings include:

  • Surfaces were not cleanable, smooth, impervious; or had cracks
  • Ceiling tiles not caulked
  • Airflow & HVAC issues: failure to maintain pressure differentials; improper location of air returns, or not changing HEPA filters as required
  • Improper PEC placement, near high traffic areas
  • Design of cleanroom not conducive to streamline workflow, introducing interruptions and contamination risk

Closing environment gaps: oversight

Besides ensuring facility renovations meet USP 797 compliance requirements, the facility should be treated as an ongoing operational responsibility. Surfaces should be routinely inspected for damage and repaired promptly, while ceilings, seals, and finishes should be checked regularly to ensure they remain cleanable and intact.

Airflow and engineering controls require the same level of oversight. Pressure differentials, HEPA maintenance, and certifier findings should be routinely reviewed and documented. Accompany the certifier and ensure they document all necessary information and understand the final certification report. Document any follow up actions after the certification.

Workflow should also be evaluated within the space itself to ensure PEC placement, material flow, and personnel movement support efficient workflow and minimize contamination risk.

Simplifi 797 can support facility oversight by helping pharmacists track the environmental and engineering controls that are often missed between certifications. It also helps ensure facility checks, maintenance intervals, and supporting documentation are completed consistently.

Annie Lambert
Clinical Program Manager for Compliance Solutions
Compliance Solution Clinical Program Manager Annie Lambert, PharmD, BCSCP is committed to providing up-to-date USP content and expert compliance guidance, and to work with you to optimize the use of our Simplifi+ pharmacy compliance solutions.

References:

  1. Alliance for Pharmacy Compounding. A Snapshot of Pharmacy Compounding in America: 2025–2026. Alliance for Pharmacy Compounding; 2026. Accessed April 17, 2026
  2. Jones B. Common findings from NABP pharmacy inspections. National Association of Boards of Pharmacy. Published August 13, 2025. Accessed April 21, 2026
  3. Shaw G. Pharmacy compliance inspection findings. Pharmacy Practice News. Published November 2025. Accessed April 19, 2026
  4. Leonowicz A. As peptides go mainstream, USP <795> and <797> matter more than ever. Pharmacy Times. Published March 6, 2026. Accessed April 26, 2026.
Back To Top